secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-205044
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics grants stock options to four top executives at $1.38 per share
-----------------------------------------------------------------------------

- CEO Pete O'Heeron granted options for 92,410 shares; CFO, CSO, and General Counsel each granted 61,607 shares.
- Vesting: 1/4th on first anniversary, then monthly over 36 months, subject to continuous service.
- Total of 277,231 stock options granted under the 2022 Stock Plan on May 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526205044/0001193125-26-205044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526205044/fblg-20260504.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-205044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer